Bioterrorism. DOD retreats on plan for anthrax vaccine.
Anthrax bacterium, once the deadly scourge of goat-hair workers, has become the bane of the U.S. defense establishment. Without infecting a single soldier, it has created a logistical headache for the Pentagon, as military contractors have fallen far short of supplying a vaccine that will protect all troops and be acceptable to health authorities. Last week military officials were forced to beat a hasty retreat in their current efforts, raising the hackles of legislators who already had serious doubts about the program.
Marshall
E
E
D000881:Anthrax / Q000517:prevention & control*; D001408:Bacillus anthracis / Q000276:immunology*; D001428:Bacterial Vaccines / Q000191:economics / Q000592:standards / Q000600:supply & distribution*; D001694:Biological Warfare / Q000517:prevention & control*; D002201:Capital Expenditures; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics; D006077:Government Agencies; D006801:Humans; D017589:Immunization Programs; D008889:Military Personnel; D014481:United States; D014486:United States Food and Drug Administration
D001428:Bacterial Vaccines